Literature DB >> 24089569

Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.

Katherine V Houser1, Melissa B Pearce, Jacqueline M Katz, Terrence M Tumpey.   

Abstract

Influenza H3N2 A viruses continue to circulate in swine and occasionally infect humans, resulting in outbreaks of variant influenza H3N2 [A(H3N2)v] virus. It has been previously demonstrated in ferrets that A(H3N2)v viruses transmit as efficiently as seasonal influenza viruses, raising concern over the pandemic potential of these viruses. However, A(H3N2)v viruses have not acquired the ability to transmit efficiently among humans, which may be due in part to existing cross-reactive immunity to A(H3N2)v viruses. Although current seasonal H3N2 and A(H3N2)v viruses are antigenically distinct from one another, historical H3N2 viruses have some antigenic similarity to A(H3N2)v viruses and previous exposure to these viruses may provide a measure of immune protection sufficient to dampen A(H3N2)v virus transmission. Here, we evaluated whether prior seasonal H3N2 influenza virus vaccination or infection affects virus replication and transmission of A(H3N2)v virus in the ferret animal model. We found that the seasonal trivalent inactivated influenza virus vaccine (TIV) or a monovalent vaccine prepared from an antigenically related 1992 seasonal influenza H3N2 (A/Beijing/32/1992) virus failed to substantially reduce A(H3N2)v (A/Indiana/08/2011) virus shedding and subsequent transmission to naive hosts. Conversely, ferrets primed by seasonal H3N2 virus infection displayed reduced A(H3N2)v virus shedding following challenge, which blunted transmission to naive ferrets. A higher level of specific IgG and IgA antibody titers detected among infected versus vaccinated ferrets was associated with the degree of protection offered by seasonal H3N2 virus infection. The data demonstrate in ferrets that the efficiency of A(H3N2)v transmission is disrupted by preexisting immunity induced by seasonal H3N2 virus infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24089569      PMCID: PMC3838242          DOI: 10.1128/JVI.02434-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  Immunogenicity and protective efficacy of influenza vaccination.

Authors:  Claude Hannoun; Francoise Megas; James Piercy
Journal:  Virus Res       Date:  2004-07       Impact factor: 3.303

2.  Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine.

Authors:  J M Katz; X Lu; S A Young; J C Galphin
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

3.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

Authors:  M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

4.  Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly.

Authors:  G J Gorse; E E Otto; D C Powers; G W Chambers; C S Eickhoff; F K Newman
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

5.  The guinea pig as a transmission model for human influenza viruses.

Authors:  Anice C Lowen; Samira Mubareka; Terrence M Tumpey; Adolfo García-Sastre; Peter Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

6.  Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012.

Authors:  Scott Epperson; Michael Jhung; Shawn Richards; Patricia Quinlisk; Lauren Ball; Mària Moll; Rachelle Boulton; Loretta Haddy; Matthew Biggerstaff; Lynnette Brammer; Susan Trock; Erin Burns; Thomas Gomez; Karen K Wong; Jackie Katz; Stephen Lindstrom; Alexander Klimov; Joseph S Bresee; Daniel B Jernigan; Nancy Cox; Lyn Finelli
Journal:  Clin Infect Dis       Date:  2013-07       Impact factor: 9.079

Review 7.  Influenza.

Authors:  N J Cox; K Subbarao
Journal:  Lancet       Date:  1999-10-09       Impact factor: 79.321

8.  The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly.

Authors:  Y Z Ghendon; A N Kaira; G A Elshina
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

9.  Genetic reassortment of avian, swine, and human influenza A viruses in American pigs.

Authors:  N N Zhou; D A Senne; J S Landgraf; S L Swenson; G Erickson; K Rossow; L Liu; K j Yoon; S Krauss; R G Webster
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

10.  Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection.

Authors:  T M Tumpey; M Renshaw; J D Clements; J M Katz
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

View more
  36 in total

1.  Aerosol Transmission from Infected Swine to Ferrets of an H3N2 Virus Collected from an Agricultural Fair and Associated with Human Variant Infections.

Authors:  Bryan S Kaplan; J Brian Kimble; Jennifer Chang; Tavis K Anderson; Phillip C Gauger; Alicia Janas-Martindale; Mary Lea Killian; Andrew S Bowman; Amy L Vincent
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

2.  Influenza A Virus Coinfection through Transmission Can Support High Levels of Reassortment.

Authors:  Hui Tao; Lian Li; Maria C White; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

3.  Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016.

Authors:  Xiangjie Sun; Joanna A Pulit-Penaloza; Jessica A Belser; Claudia Pappas; Melissa B Pearce; Nicole Brock; Hui Zeng; Hannah M Creager; Natosha Zanders; Yunho Jang; Terrence M Tumpey; C Todd Davis; Taronna R Maines
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

4.  Egg-adaptive mutations in H3N2v vaccine virus enhance egg-based production without loss of antigenicity or immunogenicity.

Authors:  Subrata Barman; John Franks; Jasmine C Turner; Sun-Woo Yoon; Robert G Webster; Richard J Webby
Journal:  Vaccine       Date:  2015-05-18       Impact factor: 3.641

5.  Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.

Authors:  Holly R Hughes; Amy L Vincent; Susan L Brockmeier; Phillip C Gauger; Lindomar Pena; Jefferson Santos; Douglas R Braucher; Daniel R Perez; Crystal L Loving
Journal:  Clin Vaccine Immunol       Date:  2015-08-19

Review 6.  Complexities in Ferret Influenza Virus Pathogenesis and Transmission Models.

Authors:  Jessica A Belser; Alissa M Eckert; Terrence M Tumpey; Taronna R Maines
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-13       Impact factor: 11.056

7.  Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.

Authors:  Jessica A Belser; Adam Johnson; Joanna A Pulit-Penaloza; Claudia Pappas; Melissa B Pearce; Wen-Pin Tzeng; M Jaber Hossain; Callie Ridenour; Li Wang; Li-Mei Chen; David E Wentworth; Jacqueline M Katz; Taronna R Maines; Terrence M Tumpey
Journal:  Virology       Date:  2017-08-29       Impact factor: 3.616

8.  Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting.

Authors:  Katelyn M Gostic; Monique Ambrose; Michael Worobey; James O Lloyd-Smith
Journal:  Science       Date:  2016-11-11       Impact factor: 47.728

9.  Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.

Authors:  Feng Liu; Vic Veguilla; F Liaini Gross; Eric Gillis; Thomas Rowe; Xiyan Xu; Terrence M Tumpey; Jacqueline M Katz; Min Z Levine; Xiuhua Lu
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

10.  Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. swine.

Authors:  Nicola S Lewis; Tavis K Anderson; Pravina Kitikoon; Eugene Skepner; David F Burke; Amy L Vincent
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.